- 4The frontline chemotherapy for patients with epithelial ovarian cancer: Focusing FLORA–05 and TaiwanHas attachmentsThe 2nd EAGOT Annual Meeting 2023 · Peng-Hui Wang (TAGO)
- 3Future Treatment of Ovarian Cancer Patients with non-BRCA Mutation or HRD (-)Has attachmentsThe 2nd EAGOT Annual Meeting 2023 · Myong Cheol Lim (KGOG)
- 2Future directions of ovarian cancer treatment after the era of PARP inhibitorsHas attachmentsThe 2nd EAGOT Annual Meeting 2023 · Kosuke Yoshihara, Niigata Univ. (JGOG)
- 1[The 1st EAGOT Annual Meeting 2023] Program for ovarian cancer committeeThe 1st EAGOT Annual Meeting 2023